Matching is based on human leukocyte antigen (HLA) typing, which is more complex than matching blood types. HLA markers are proteins on most cells in the body, and a close match between donor and recipient HLA markers reduces the risk of complications such as graft-versus-host disease (GVHD). The Be The Match Registry uses this information to find the best possible match for patients.
